CVI Holdings LLC acquired a new stake in shares of Valeritas Holdings Inc (NASDAQ:VLRX) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 2,557,266 shares of the company’s stock, valued at approximately $832,000. Valeritas accounts for about 1.9% of CVI Holdings LLC’s investment portfolio, making the stock its 10th largest position. CVI Holdings LLC owned approximately 0.10% of Valeritas as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of VLRX. Northern Trust Corp raised its stake in shares of Valeritas by 855.4% during the fourth quarter. Northern Trust Corp now owns 185,469 shares of the company’s stock valued at $60,000 after purchasing an additional 166,057 shares during the period. Renaissance Technologies LLC raised its stake in shares of Valeritas by 730.3% during the third quarter. Renaissance Technologies LLC now owns 163,650 shares of the company’s stock valued at $218,000 after purchasing an additional 143,940 shares during the period. Finally, Geode Capital Management LLC raised its stake in shares of Valeritas by 138.0% during the fourth quarter. Geode Capital Management LLC now owns 186,971 shares of the company’s stock valued at $60,000 after purchasing an additional 108,416 shares during the period.

A number of analysts have recently weighed in on the stock. Zacks Investment Research downgraded shares of Valeritas from a “buy” rating to a “hold” rating in a research report on Saturday, March 9th. BTIG Research assumed coverage on shares of Valeritas in a research report on Tuesday, December 4th. They set a “buy” rating and a $1.00 price target for the company. Finally, Oppenheimer set a $2.00 price target on shares of Valeritas and gave the stock a “buy” rating in a research report on Wednesday, November 21st. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $2.10.

VLRX stock opened at $0.39 on Friday. Valeritas Holdings Inc has a twelve month low of $0.30 and a twelve month high of $4.58. The company has a debt-to-equity ratio of 2.82, a current ratio of 4.47 and a quick ratio of 3.98. The company has a market cap of $9.98 million, a PE ratio of -0.23 and a beta of 2.10.

In related news, major shareholder Armistice Capital Master Fund purchased 150,000 shares of the firm’s stock in a transaction dated Thursday, December 20th. The stock was acquired at an average price of $0.34 per share, with a total value of $51,000.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.80% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION NOTICE: This piece was reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this piece on another site, it was illegally stolen and reposted in violation of U.S. and international copyright law. The legal version of this piece can be read at

About Valeritas

Valeritas Holdings, Inc, a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States and China. It offers V-Go, a wearable insulin delivery device for basal-bolus therapy. The company also develops h-Patch, a controlled delivery technology platform; Mini-Ject technology for needle-free injection systems; and Micro-Trans technology for microneedle design, fabrication, and drug delivery.

See Also: Why do earnings reports matter?

Want to see what other hedge funds are holding VLRX? Visit to get the latest 13F filings and insider trades for Valeritas Holdings Inc (NASDAQ:VLRX).

Institutional Ownership by Quarter for Valeritas (NASDAQ:VLRX)

Receive News & Ratings for Valeritas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas and related companies with's FREE daily email newsletter.